Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CRESTONE, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-09 to 2026-01-31
Current total value of award: $28613040
Description: TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.